Company Filing History:
1 out of 1 
1 out of 19 Years Active: 2019
Title: The Innovations of Bor-rung Ou
Introduction
Bor-rung Ou is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of cancer detection. His work focuses on the development of biomarkers that can aid in the early diagnosis of diseases related to human papilloma virus (HPV).
Latest Patents
Bor-rung Ou holds a patent for a peptide, specifically a THLW peptide, which is represented by the amino acid sequence SEQ ID No. 1. This peptide serves as a biomarker for diseases such as oral cancer and cervical cancer. The patent outlines a method for assessing the risk of oral cancer by utilizing this peptide, which can be used to detect the potential development of cancer in individuals.
Career Highlights
Throughout his career, Bor-rung Ou has worked with esteemed institutions such as Tungchai University and Taichung Veterans General Hospital. His research has been pivotal in advancing the understanding of cancer biomarkers and their applications in clinical settings.
Collaborations
Some of his notable coworkers include Feng-Di Lung and Ye-song Gu. Their collaborative efforts have contributed to the success of his research and the development of innovative solutions in cancer detection.
Conclusion
Bor-rung Ou's contributions to the field of medical research, particularly in cancer detection, highlight the importance of innovation in improving healthcare outcomes. His work with the THLW peptide represents a significant advancement in the early diagnosis of cancer, showcasing the potential of biomarker research.